Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.
Quan J, Ma C, Panaccione R, Hracs L, Sharifi N, Herauf M, Markovinović A, Coward S, Windsor JW, Caplan L, Ingram RJM, Charlton C, Kanji JN, Tipples G, Holodinsky JK, Bernstein CN, Mahoney DJ, Bernatsky S, Benchimol EI, Kaplan GG; STOP COVID-19 in IBD Research Group.
Quan J, et al. Among authors: kaplan gg.
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1077-1079. doi: 10.1016/S2468-1253(22)00340-5. Epub 2022 Oct 26.
Lancet Gastroenterol Hepatol. 2022.
PMID: 36306801
Free PMC article.
No abstract available.